ACADIAN ASSET MANAGEMENT LLC

Position in BDTX — Black Diamond Therapeutics, Inc.

CIK 916542 Boston, MA

Position in BDTX

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$5,002,626

+$1,041,306 QoQ

Shares Held

2,348,651

+44.1% QoQ

Ownership

4.10%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2022

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

ACADIAN ASSET MANAGEMENT LLC holds $658,704,928 across 179 Biotechnology names. BDTX ranks #23 (0.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INCY	Incyte Corp	1,900,824	$178,905,554
2	REGN	Regeneron Pharmaceuticals, Inc.	151,191	$116,816,214
3	LEGN	Legend Biotech Corp	1,527,336	$27,629,508
4	TBPH	Theravance Biopharma, Inc.	1,276,576	$20,718,828
5	RIGL	Rigel Pharmaceuticals Inc	666,426	$18,020,159
6	IMCR	Immunocore Holdings plc	501,091	$15,107,893
7	PRTA	Prothena Corp Public Ltd Co	1,547,593	$15,042,603
8	PBYI	Puma Biotechnology, Inc.	2,041,759	$13,046,840

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$5,002,626	2,348,651	+44.1%	Shares	Defined	2026-05-13
2025-12-31	$3,961,320	1,630,173	+238.8%	Shares	Defined	2026-02-10
2025-09-30	$1,823,456	481,123	+3113.7%	Shares	Defined	2025-11-13
2025-03-31	$23,205	14,971	-25.8%	Shares	Defined	2025-05-21
2024-12-31	$43,153	20,165	-88.2%	Shares	Defined	2025-02-11
2024-03-31	$864,485	170,510	+13.8%	Shares	Defined	2024-05-10
2023-12-31	$421,202	149,894	+180.9%	Shares	Defined	2024-02-13
2023-06-30	$269,493	53,365	0.0%	Shares	Defined	2023-08-07
2023-03-31	$100,859	53,365	0.0%	Shares	Defined	2023-05-11
2022-12-31	$96,057	53,365	—	Shares	Defined	2023-02-14
No filing history on record for this holder in this stock.